RU2011149683A - METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY - Google Patents

METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY Download PDF

Info

Publication number
RU2011149683A
RU2011149683A RU2011149683/02A RU2011149683A RU2011149683A RU 2011149683 A RU2011149683 A RU 2011149683A RU 2011149683/02 A RU2011149683/02 A RU 2011149683/02A RU 2011149683 A RU2011149683 A RU 2011149683A RU 2011149683 A RU2011149683 A RU 2011149683A
Authority
RU
Russia
Prior art keywords
treating secondary
secondary hypogonadism
drug
obesity
units
Prior art date
Application number
RU2011149683/02A
Other languages
Russian (ru)
Inventor
Иван Иванович Дедов
Роман Викторович Роживанов
Дмитрий Геннадиевич Курбатов
Original Assignee
Федеральное государственное бюджетное учреждение "Эндокринологический научный центр" Министерства здравоохранения и социального развития
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Эндокринологический научный центр" Министерства здравоохранения и социального развития filed Critical Федеральное государственное бюджетное учреждение "Эндокринологический научный центр" Министерства здравоохранения и социального развития
Priority to RU2011149683/02A priority Critical patent/RU2011149683A/en
Publication of RU2011149683A publication Critical patent/RU2011149683A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Способ лечения вторичного гипогонадизма у репродуктивно активных мужчин с ожирением, отличающийся тем, что назначается тамоксифен в индивидуально подобранной суточной дозе, при которой уровни общего тестостерона, лютеинизирующего и фолликулостимулирующего гормонов в крови на фоне приема препарата более 12 нмоль/л, 2,5 Ед/л и 1,6 Ед/л, соответственно, общая продолжительность лечения после завершения подбора дозы препарата 3-6 месяцев. A method of treating secondary hypogonadism in reproductively active obese men, characterized in that tamoxifen is prescribed in an individually selected daily dose at which the levels of total testosterone, luteinizing and follicle-stimulating hormones in the blood when taking the drug are more than 12 nmol / l, 2.5 Units / l and 1.6 units / l, respectively, the total duration of treatment after completion of the selection of a dose of the drug 3-6 months.

Claims (1)

Способ лечения вторичного гипогонадизма у репродуктивно активных мужчин с ожирением, отличающийся тем, что назначается тамоксифен в индивидуально подобранной суточной дозе, при которой уровни общего тестостерона, лютеинизирующего и фолликулостимулирующего гормонов в крови на фоне приема препарата более 12 нмоль/л, 2,5 Ед/л и 1,6 Ед/л, соответственно, общая продолжительность лечения после завершения подбора дозы препарата 3-6 месяцев. A method of treating secondary hypogonadism in reproductively active obese men, characterized in that tamoxifen is prescribed in an individually selected daily dose at which the levels of total testosterone, luteinizing and follicle-stimulating hormones in the blood when taking the drug are more than 12 nmol / l, 2.5 Units / l and 1.6 units / l, respectively, the total duration of treatment after completion of the selection of a dose of the drug 3-6 months.
RU2011149683/02A 2011-12-06 2011-12-06 METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY RU2011149683A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011149683/02A RU2011149683A (en) 2011-12-06 2011-12-06 METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011149683/02A RU2011149683A (en) 2011-12-06 2011-12-06 METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY

Publications (1)

Publication Number Publication Date
RU2011149683A true RU2011149683A (en) 2013-06-20

Family

ID=48784916

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011149683/02A RU2011149683A (en) 2011-12-06 2011-12-06 METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY

Country Status (1)

Country Link
RU (1) RU2011149683A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2733465C1 (en) * 2019-08-15 2020-10-01 Алексей Владимирович Громов Method of treating hypogonadotropic hypogonadism, nasal spray as method for administering gonadorelin acetate in treating hypogonadotropic hypogonadism

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2733465C1 (en) * 2019-08-15 2020-10-01 Алексей Владимирович Громов Method of treating hypogonadotropic hypogonadism, nasal spray as method for administering gonadorelin acetate in treating hypogonadotropic hypogonadism

Similar Documents

Publication Publication Date Title
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
IN2015DN00450A (en)
MX2013004873A (en) Methods and compositions for treating hiv-associated diarrhea.
AR086395A1 (en) PACKAGE FOR TREATMENT OF PATHOLOGIES
RU2011149683A (en) METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY
AR116592A1 (en) TREATMENT OF PRIMARY BILIARY CHOLANGITIS AND PRIMARY SCLEROSING CHOLANGITIS WITH BARICITINIB
UA52483U (en) Method for treating idiopathic pathospermia
RU2010126066A (en) METHOD FOR TREATING SECONDARY HYPOGONADISM IN REPRODUCTIVELY ACTIVE MEN WITH OBESITY
MX2023006765A (en) Method of providing celiprolol therapy to a patient.
RU2011120773A (en) METHOD FOR TREATING SECONDARY LACTASE INSUFFICIENCY
FR2984370B1 (en) IMPLANTABLE AND IMPLANT KNIT FOR THE TREATMENT OF PELVIC STATIC PROLAPSUS COMPRISING SUCH A KNIT
UA116484U (en) METHOD OF TREATMENT OF HYPERTENSION WITH METABOLIC SYNDROME
UA66404U (en) Method for preventing and treating osteoporosis in pregnant patients with perinatal infection
Hariri IgE-mediated allergic reaction in an elderly patient: case report
MY174065A (en) Methods and compositions for treating hiv-associated diarrhea
UA103632U (en) Method for complex treatment of patients with anxious depression
RU2013126574A (en) METHOD FOR NIGHT FOOD SYNDROME CORRECTION IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS
UA44813U (en) Method for preventing endometrial hyperplasia in women of reproductive age with chronic inflammations of small pelvis
UA84197U (en) Method for medical rehabilitation of patients with irritated bowel syndrome combined with neurocirculatory dystonia
Tamai Acute cholangitis: case report
UA84715U (en) Method for treating diabetes mellitus type 2 with obesity
RU2011117898A (en) METHOD FOR TREATING PAPILLOMAVIRUS INFECTION
RU2012135942A (en) METHOD FOR TREATING PATIENTS WITH GALLSTONE DISEASE OF THE FIRST STAGE
UA75277U (en) Method for treating dystrophic diseases of retina and choroid
UA79721U (en) Method for treating patients with post-infarction cardiosclerosis and concomitant obesity

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20131004